Preview

Онкоурология

Расширенный поиск

КРИОАБЛЯЦИЯ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ

https://doi.org/10.17650/1726-9776-2011-7-2-96-100

Полный текст:

Аннотация

Криоабляция предстательной железы является эффективным, минимально инвазивным методом лечения рака предстательной железы (РПЖ), который может применяться как первично, так и в случае рецидива опухоли после лучевой терапии. Благодаря постоянному усовершенствованию оборудования для криоабляции число осложнений лечения невелико. Изучение отдаленных результатов криотерапии РПЖ – раковоспецифической выживаемости, выживаемости без метастазов и др. – продолжается в настоящее время. Фокальная криоабляция предстательной железы остается экспериментальным видом терапии.

Об авторах

А. В. Говоров
Кафедра урологии МГМСУ
Россия


Д. Ю. Пушкарь
Кафедра урологии МГМСУ
Россия


В. Ю. Иванов
ГКБ № 50, Москва
Россия


Список литературы

1. Patel B.G., Parsons C.L., Bidair M. et al. Cryoablation for carcinoma of the prostate. J Surg Oncol 1996;63:256–64.

2. Lam J.S., Shvarts O., Belldegrun A.S. A new era for cryotherapy of prostate cancer? Cont Urol 2004;16(10):46–61.

3. Gonder M.J., Soanes W.A., Schulman S. Cryosurgical treatment of the prostate. Invest Urol 1966;3:372–8.

4. Flocks R.H., Nelson C.M., Boatman D.L. Perineal cryosurgery for prostatic carcinoma. J Urol 1972;108:933–5.

5. Megalli M.R., Gursel E.O., Veenema R.J. Closed perineal cryosurgery in prostate cancer. New probe and technique. Urology 1974;4:220–2.

6. Onik G. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993;72:1291–9.

7. Lee F. US-guided percutaneous cryoablation of the prostate cancer. Radiology 1994;192:769–6.

8. Cohen J., Miller R.J., Shuman B.A. Urethral warming catheter for use during cryoablation of the prostate. Urology 1995;45:861–4.

9. Tatsutani K., Rubinsky M., Onik G. et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996;48:441–7.

10. Baust J.G., Gage A.A. The molecular basis of cryosurgery. BJU International 2005;95:1187–91.

11. Gage A.A., Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998;37(3):171–86.

12. Larsson T.R., Robertson D.W., Corica A. et al. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathologic outcomes. Urology 2000;55(4):547–52.

13. Cytron S., Greene D., Witzsch U. et al. Cryoablation of the prostate: technical recommendations. Prostate Cancer Prostatic Dis 2009;1:1–8.

14. Babaian R.J., Donnelly B., Bahn D. et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008;180:1993–2004.

15. Long J.P., Bahn D., Lee F. et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001;57(3):518–23.

16. Donnelly B.J., Saliken J.C., Ernst D.S. et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002; 60(4):645–9.

17. Jones J.S., Rewcastle J.C., Donnelly B.J. et al. Whole gland primary prostate cryoablation: initial results from the Cryo On-line Data Registry. J Urol 2008;180:554–8.

18. Roach M. III, Hanks G., Thames H. Jr. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965–74.

19. Cohen J.K., Miller R.J., Ahmed S. et al. Ten-year biochemical disease ontrol for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 2008;71:515–8.

20. Levy D.A., Pisters L.L., Jones J.S. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol 2009;182:931–7.

21. Levy D., Avallone A., Jones J.S. Current state of urological cryosurgery: prostate and kidney. BJU Int 2010;105:590–600.

22. Prepelica K.L., Okeke Z., Murphy A. et al. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005;15:1625–30.

23. Han K.R., Cohen J.K., Miller R.J. et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003;170(4 Pt 1): 1126–30.

24. Bahn D.K., Lee F., Badalament R. et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002;60(2 Suppl 1):3–11.

25. Chin J.L., Lim D., Abdelhady M. Review of primary and salvage cryoablation for prostate cancer. Cancer Control 2007;14(3):231–7.

26. Pisters L.L., Leibovici D., Blute M. et al. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009;182:517–27.

27. Izawa J.I., Perrotte P., Greene G.F. et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001;165:867–70.

28. Spiess P.E., Lee A.K., Leibovici D. et al. Presalvage prostate-specific antigen and PSAdoubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006;107:275–80.

29. Levy D.A., Pisters L.L., Jones J.S. Impact of nadir post salvage cryoablation prostate specific antigen level on biochemical disease-free survival. Chicago, Il: Annual Meeting AUA 2009:abstr. 1981.

30. Donnelly B.J., Saliken J.C., Ernst D.S. et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 2005;8:235–42.

31. Ghafar M.A., Johnson C.W., De la Taille A. et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001;166:1333–8.

32. Chin J.L., Pautler S.E., Mouraviev V. et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001;165(6 Pt 1): 1937–41.

33. Pisters L.L., von Eschenbach A.C., Scott S.M. et al. The efficacy and complications of salvage cryoyherapy of the prostate. J Urol 1997;157(3):921–5.

34. Shelley M., Wilt T.J., Coles B. et al. Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev 2007, July 18(3): CD005010.

35. Onik G., Narayan P., Vaughan D. et al. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 2002;60(1):109–14.

36. Lambert E.H., Bolte K., Masson P. et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007;69:1117–20.

37. Onik G., Vaughan D., Lotenfoe R. et al. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008;26:500–5.

38. Barqawi A., Crawford E.D. Focal therapy in prostate cancer: future trends. BJU International 2005;95:273–4.


Для цитирования:


Говоров А.В., Пушкарь Д.Ю., Иванов В.Ю. КРИОАБЛЯЦИЯ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ. Онкоурология. 2011;7(2):96-100. https://doi.org/10.17650/1726-9776-2011-7-2-96-100

For citation:


Govorov A.V., Pushkar D.Y., Ivanov V.Y. PROSTATE CRYOABLATION. Cancer Urology. 2011;7(2):96-100. (In Russ.) https://doi.org/10.17650/1726-9776-2011-7-2-96-100

Просмотров: 416


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)